Texas drug manufacturer smacked with FDA warning letter over multiple violations
A Texas drug manufacturing facility has drawn the FDA’s ire over missing records, inadequate processes and faulty controls on a laundry list of infractions outlined …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.